Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia [Phase 1]

View source ↗

Summary

This update confirms the completion of a Phase 1 pharmacokinetics, pharmacodynamics, and safety study of Z-213 for iron deficiency anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Z-213

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Iron Deficiency Anemia | Phase 1 | Status: COMPLETED